Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
Stroke, Cerebral Ischemia, Brain Infarction
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Fibrinogen, Reperfusion, Thrombolysis
Eligibility Criteria
Inclusion Criteria: Acute, ischemic stroke with first symptoms within 6 hours of beginning treatment Baseline NIHSS > 5 Exclusion Criteria: No intracranial, extravascular blood on CT Hypertension (systolic > 185; diastolic > 105) Baseline fibrinogen level < 100 mg/dL Thrombocytopenia (< 100,000 / mm3) Recent (< 3 days) or anticipated (< 5 days) use of a thrombolytic agent Recent (< 14 days) or anticipated surgery
Sites / Locations
- Mayo Clinic Hospital / Arizona
- Sparks Regional Medical Center
- Loma Linda University School of Medicine
- Santa Monica - UCLA Medical Center
- UCLA Medical Center
- Hoag Memorial Hospital
- The Neurology Center: Tri-City Medical Center
- Shasta Regional Medical
- Bridgeport Hospital
- Neurologic Consultants, P.A.
- Shands Jacksonville / University of Florida
- Ocala Neurodiagnostic Center
- Florida Hospital Neuroloscience Institute
- Fawcett Memorial Hospital
- Peace River Regional Medical Center
- Tallahassee Memorial Healthcare, Inc.
- The Queens Medical Center, Neuroscience Institute
- Mercy Hospital
- Elkhart Clinic, LLC - Neurology
- Fort Wayne Neurological Center
- Parkview Research Center
- Sinai Hospital of Baltimore
- Baystate Medical Center
- Wayne State University
- St. Mary's Duluth Clinic
- Minneapolis Clinic of Neurology
- Deaconess Billings Clinical Research Center
- NJ Neuroscience Institute
- Neurology Consultants Of Burlington County
- UMDNJ / Robert Wood Johnson Medical School
- Neurology Group of Bergen County
- Shore Neurology
- Kaleida Stroke Center
- United Health Services Hospitals
- Winthrop University Hospital
- Weill Medical College of Cornell University
- Rochester General Hospital
- Strong Memorial Hospital
- Presbyterian Hospital
- Lebauer Cardiovascular Research Foundation at Moses Cone Hospital
- Clinical Research of Winston-Salem
- The Toledo Hospital
- Medical University of Ohio
- Northshore Clinical Associates
- Westmoreland Neurology Associates, Inc.
- Miriam Hospital
- Beaufort Memorial Hospital
- Methodist University Hospital
- Brackenridge Hospital
- Seton Medical Center
- Methodist Hospital / Neurological Institute
- University of Texas Health Sciences Center
- Virginia Commonwealth University
- Neurological Consultants of Virginia Beach
- Harborview Medical Center
- Madigan Army Medical Center
- St. Lukes Medical Center
- Medical College of Wisconsin
- Gosford Hospital Department of Neurology
- Flinders Medical Centre
- Box Hill Hospital
- National Stroke Research Institute
- Grey Nuns Community Hospital
- Western Memorial Health Clinic
- London Health Sciences Centre - University Hospital
- Trillum Health Centre
- Hospital Charles-Leymoyne
- University of Alberta Hospital
- Thunder Bay Regional Health Sciences Centre
- St. Anne's Faculty Hospital
- Faculty Hospital 1, The Clinic of Neurology
- St. Anna Hospital
- University Clinical Hospital
- City Hospital #31
- Research Institute of Neurology RAMS
- Military Medical Akademy Dept of Neurology
- St. Augustine's Hospital
- Tiervlei Trial Centre
- Vergelegen Medi-Clinic
- Sunninghill Hospital
- Changhua Christian Hospital, Chief Department of Neurology
- Lo-Tung Pohai Hospital, Department of Neurology
- Chung-Ho Memorial Hospital Kaohsiung Medical University
- Kaohsiung Chang-Gung, Memorial Hospital
- Chung Shan Medical Hospital
- China Medical University Hospital
- Taichung Veterans General Hospital, Section of Neurology
- Kuang-Tien General Hospital
- Chi-Mei Medical Center
- National Taiwan University Hospital
- Cathay General Hospital Department of Neurology
- Shin-Kong WHS Memorial Hospital
- Tri-Service General Hospital
- Far Eastern Memorial Hospital
- En Chu Kong Hospital
- Chang-Gung Memorial Hospital Linko Medical Center
- Chang-Gung Memorial Hospital, Linko Medical Center
- University of Aberdeen, Polwarth Building, Institute of Medical Sciences, Dept. of Medicine & Theropeutics
- Institute of Neurological Sciences Southern General Hospital
- Royal Victoria Infirmary - Clinical Research Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Intravenous ancrod
Intravenous Placebo
Intravenous ancrod infused at a rate of 0.167 IU/kg/hr (0.6 mL/kg/hr) for 2 or 3 hours depending on the pretreatment fibrinogen level.
Intravenous placebo at a rate of 0.6 mL/kg/hr for 2 or 3 hours depending on the pretreatment fibrinogen level.